PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Use of naltrexone reduces inflammation in Crohn's patients

2011-05-20
(Press-News.org) Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract causing abdominal pain, diarrhea, gastrointestinal bleeding and weight loss. Treatments for Crohn's disease are designed to reduce the inflammation but may be associated with rare but serious side effects, including infections and lymphoma. Research suggests that endorphins and enkephalins, part of the opioid system, have a role in the development or continuation of inflammation.

Naltrexone is a drug used to help recovering alcoholics and drug users stay clean. It inhibits the body's opioid system that regulates pain and is involved in cell growth, repair and inflammation. Naltrexone binds to a protein receptor that blocks the effects of opioids, including the body's own enkephalins and endorphins, substances that reduce pain and produce a feeling of wellbeing.

"Although the cause of Crohn's disease is unknown, research suggests it involves a complex interplay of environmental, genetic, microbial, immune and nonimmune factors," said Jill P. Smith, M.D., professor of medicine. "We hypothesize that the opioid system is involved in inflammatory bowel disease and that interfering with an opioid receptor will lead to the reversal of the inflammation."

Researchers studied 40 patients with active Crohn's disease. Patients received either naltrexone or a placebo for 12 weeks. All patients then continued on naltrexone for an additional 12 weeks. This was a double-blind study with neither the patient or healthcare provider knowing which treatment was being received.

Eighty-eight percent of those treated with naltrexone had at least a 70-point decline in Crohn's Disease Activity Index scores compared to 40 percent of placebo-treated patients. CDAI is a point system used to quantify symptoms in Crohn's patients. Researchers noted no statistical difference at four or eight weeks of treatment, suggesting a response requires at least 12 weeks of treatment. Results were published in the journal Digestive Diseases and Sciences.

Gastrointestinal inflammation was evaluated by appearance of the intestine on colonoscopy and scores from biopsy specimens. After 12 weeks, researchers noted no change in those taking a placebo. However, 78 percent of those on naltrexone experienced healing in the lining of the intestine.

For those patients who received a placebo for 12 weeks and then were placed on naltrexone for the following 12 weeks, 70 percent experienced at least a 70-point decline in the CDAI score and healing of the colon as seen on colonoscopy. Patients who continued use of naltrexone for an additional 12 weeks (24 total weeks) had a further 75-point decline in CDAI scores, leading to remission (score of less than 150) in 50 percent of the patients.

"We report that naltrexone improves clinical and inflammatory activity of subjects with moderate to severe Crohn's disease compared to placebo-treated controls," Smith said.

The researchers are planning clinical trials to look at use of naltrexone in children with Crohn's disease and have secured orphan drug status from the Food and Drug Administration for the use of naltrexone in children with Crohn's disease. Smith and Zagon hold a patent for the use of naltrexone in inflammatory bowel disease -- Crohn's disease and ulcerative colitis.

INFORMATION:

The National Institutes of Health's Broad Medical Research Program funded this project.

Other researchers on the project are Ian Zagon, Ph.D., Department of Neural and Behavioral Sciences; Sandra I. Bingaman, R.N., Aparna Mukherjee, M.D., and Christopher O. McGovern, B.S., Department of Medicine; Francesco Ruggiero, M.D., Department of Pathology; and David Mauger, Ph.D., Department of Public Health Sciences.

END



ELSE PRESS RELEASES FROM THIS DATE:

The peculiar feeding mechanism of the first vertebrates

The peculiar feeding mechanism of the first vertebrates
2011-05-20
Jaws made of bone are commonplace in the animal kingdom. However, how jaws developed in the course of evolution is still a mystery. Under the direction of paleontologist Nicolas Goudemand, a team of researchers from the University of Zurich and the European Synchrotron Radiation Facility set about solving this puzzle. Living and extinct jawless animals can yield clues as to the development of the jaw. The researchers studied fossilized conodonts – extinct, eel-shaped animals whose precise relationship with the actual vertebrates is still a matter of debate. For their project, ...

Orange County Full Service Marketing Firm Announces New Website and Services

Orange County Full Service Marketing Firm Announces New Website and Services
2011-05-20
Tang Marketing Group, a growing marketing and branding consulting firm with offices in the West an East Coast United States, announced today the launch of their new website www.tangmarketinggroup.com. The Orange County-based firm specializes in branding, social media marketing, stylish business concepts, publications, online marketing and public relations. As expressed by Tang Marketing Group's President, Christina Tang, "By applying the power of branding, we work to create positive images and credible brand language that both ignites brand recognition and ...

Viagra could reduce multiple sclerosis symptoms

Viagra could reduce multiple sclerosis symptoms
2011-05-20
Universitat Autònoma de Barcelona researchers have discovered that Viagra® drastically reduces multiple sclerosis symptoms in animal models with the disease. The research, published in Acta Neuropathologica, demonstrates that a practically complete recovery occurs in 50% of the animals after eight days of treatment. Researchers are confident that clinical trials soon will be carried out in patients given that the drug is well tolerated and has been used to treat sexual dysfunction in some multiple sclerosis patients. Multiple sclerosis is the most common chronic inflammatory ...

Prompt Proofing Blog Post - Writing Business Emails, Part 1

2011-05-20
How many emails arrive in your inbox on a daily basis? If you're running a business I would guess the number might be into 3 digits. How do you deal with these? How do you detect and eliminate spam and focus on the messages you really need? Well, what do you know, the recipients of your emails use the same filters! Email is now the dominant means of business communication; some people might like a phone call, but for the most part email is the preferred form of communication. Unlike a phone call, you have a written record of what has been said so there is no confusion ...

Exercise helps women fight smoking cravings, but effect is short-lived

2011-05-20
PROVIDENCE, R.I. [Brown University] — Dozens of studies on whether moderate exercise can curb the nicotine cravings of women smokers have added up to an apparent contradiction: it seems to work in short-term, well controlled lab experiments, but then fizzles out in treatment trials. A new study may explain why and help researchers devise a practical therapy. The explanation suggested in the results of research led by David Williams, an assistant professor of community health at Brown University, is that while exercise does help improve the mood of smokers and curtail ...

Studies focus on feed ingredient's effects on levels of E. coli O157:H7 in cattle

2011-05-20
After corn is processed to make ethanol, what's left of the corn looks something like slightly dampened cornmeal, though a somewhat darker yellow, and not as finely ground. Known as "wet distiller's grains with solubles" (WDGS), this byproduct is sometimes used as a cattle feed ingredient. U.S. Department of Agriculture (USDA) scientists in Clay Center, Neb., are studying the pros and cons of that practice. WDGS are rich in protein, and also provide calories and minerals, according to James E. Wells, a microbiologist with USDA's Agricultural Research Service (ARS). Since ...

Venn Digital Announce New Marketing Partnership

Venn Digital Announce New Marketing Partnership
2011-05-20
Digital marketing agency Venn Digital has announced the formation of a new partnership with email marketing agency Profunnel to deliver new "Marketing Automation" software to boost the success of their clients' email marketing campaigns. Venn Digital has built a strong reputation as a digital marketing agency that delivers the desired results of their clients. Their wide experience and expertise in creating effective digital marketing strategies enables them to build bespoke campaigns tailored to attain the exact goals of their clients. Profunnel are equally ...

LSU researchers study methods to use river sediment to repair the coast

2011-05-20
BATON ROUGE – They say that time and tide wait for no man – well, neither does the mighty Mississippi River. As the already gargantuan body of water swells beyond its normal manmade boundaries, the state of Louisiana is starting to see impact after having seen the damage already done to states from Missouri to Mississippi. While near record-breaking water levels are expected any day now and safety precautions are being taken, one LSU professor explained how the river's meandering historic path and silty contents might offer a future ray of hope. "Historically, the Mississippi ...

Record efficiency of 18.7 percent for flexible CIGS solar cells on plastics

2011-05-20
It's all about the money. To make solar electricity affordable on a large scale, scientists and engineers worldwide have long been trying to develop a low-cost solar cell, which is both highly efficient and easy to manufacture with high throughput. Now a team at Empa's Laboratory for Thin Film and Photovoltaics, led by Ayodhya N. Tiwari, has made a major step forward. "The new record value for flexible CIGS solar cells of 18.7% nearly closes the "efficiency gap" to solar cells based on polycrystalline silicon (Si) wafers or CIGS thin film cells on glass", says Tiwari. He ...

New commitments to save women and children

2011-05-20
GENEVA, 19 May 2011: Today 16 countries announced new commitments to dramatically reduce maternal, newborn and child mortality, as part of the Global Strategy for Women's and Children's Health. "Political and financial support for action on women's and children's health is reaching new and encouraging heights. The commitments build on the momentum of recent months, and prove that saving the lives of the most vulnerable can attract support at the highest levels," says Ban Ki-moon, the United Nations Secretary-General, who is leading the Every Woman Every Child campaign ...

LAST 30 PRESS RELEASES:

Small nuclear RNA base editing a safer alternative to CRISPR, UC San Diego researchers find

Can Hayabusa2 touchdown? New study reveals space mission’s target asteroid is tinier and faster than thought

Millisecond windows of time may be key to how we hear, study finds

Graz University of Technology opens up new avenues in lung cancer research with digital cell twin

Exoplanets are not water worlds

Study shows increasing ‘healthy competition’ between menu options nudges patients towards greener, lower-fat hospital food choices

New insights into melanoma plasticity uncover a critical role of iron metabolism

A graphene sandwich — deposited or transferred?

New light-powered motor fits inside a strand of hair

Oil rig study reveals vital role of tiny hoverflies

Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network

iRECODE: A new computational method that brings clarity to single-cell analysis

New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey

QUT scientists create material to turn waste heat into clean power

Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health

Cosmic crime scene: White dwarf found devouring Pluto-like icy world

Major report tackles Covid’s cardiovascular crisis head-on

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

[Press-News.org] Use of naltrexone reduces inflammation in Crohn's patients